Medical Device Global Market Access cover art

Medical Device Global Market Access

Medical Device Global Market Access

By: Pure Global
Listen for free

About this listen

 Navigate every market. Accelerate every launch. Medical Device Global Market Access by Pure Global is the audio briefing that turns the world’s most confusing regulatory pathways into clear, actionable roadmaps. If you’re a MedTech founder, RA/QA leader, product manager, or investor who needs to get devices cleared anywhere from Austin to Abu Dhabi, this show is your shortcut. Why listen? • Step-by-step playbooks – We decode EU MDR, U.S. 510(k), Brazil’s ANVISA, China’s NMPA, and 25 + other regimes, showing exactly how long each milestone really takes and where companies get stuck. • First-hand war stories – Hear candid interviews with regulatory veterans who have shepherded implants, software, wearables, diagnostics, and AI algorithms to market—and lived to tell the tale. • Real-time intelligence – Every episode covering the week’s new guidances, standards, and enforcement trends so you’re always ahead of the curve. • Actionable templates – From clinical evaluation checklists to technical-file skeletons, we break down the documents you’ll need and the pitfalls reviewers love to flag. • AI-powered insights – Because Pure Global mines millions of public filings, tenders, and recalls, we surface data-backed best practices you won’t hear at conferences—or from competitors. What you’ll hear • Launching SaMD under multiple risk classes in parallel • Surviving an unannounced ISO 13485 audit • Building a “reg-first” QMS that scales • Mastering Latin-American registrations without endless language cycles • Leveraging real-world evidence to shorten clinical timelines • Aligning cybersecurity, privacy, and post-market surveillance rules across regions Whether you’re plotting first entry, managing lifecycle expansions, or rescuing a delayed submission, subscribing could shave months—and millions—off your path to revenue. ⸻ Brought to you by Pure Global – the AI-native consultancy that already guides MedTech innovators through regulatory and market-access hurdles in 30 + countries. Ready for expert help on your next submission? Visit https://pureglobal.com or email info@pureglobal.com to start accelerating today.Copyright 2026 Pure Global
Episodes
  • Winning the Heart: MedTech's Race for a Full Structural Heart Ecosystem by 2026

    Winning the Heart: MedTech's Race for a Full Structural Heart Ecosystem by 2026
    Apr 10 2026
    This episode explores the future of the structural heart market, a key growth area in MedTech. We discuss the technological advancements in imaging, catheter tools, and procedural guidance that are shaping the industry. We analyze how leading companies like Edwards Lifesciences, Medtronic, Abbott, and Boston Scientific are moving beyond single implants to create comprehensive procedural ecosystems, and what this means for market leadership by 2026. - Why is the structural heart market one of MedTech's most attractive growth arenas? - How are advancements in imaging and catheters changing cardiac procedures? - What does it mean to own the full "ecosystem" in structural heart therapy? - Which companies are best positioned to dominate the market by 2026? - How is the focus shifting from a single device to a complete procedural solution? - What are the key differences between TAVR and TMVR procedures? - What role will AI and advanced software play in the future of structural heart interventions? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access with local expertise and advanced AI. We help you develop regulatory strategies, prepare technical dossiers, and act as your local representative in over 30 markets. From market selection to post-market surveillance, our technology-driven solutions ensure efficiency and compliance. Whether you are a startup or a multinational enterprise, Pure Global provides scalable support to bring your innovations to market faster. Contact us at info@pureglobal.com, visit https://pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.
    Show More Show Less
    3 mins
  • The 2026 Neurotechnology Leap: Navigating BCI Commercialization, Reimbursement, and FDA Hurdles

    The 2026 Neurotechnology Leap: Navigating BCI Commercialization, Reimbursement, and FDA Hurdles
    Apr 9 2026
    This episode explores the imminent commercialization of Brain-Computer Interface (BCI) technology, moving it from a futuristic concept to a medical reality by 2026. We examine the four critical non-technical hurdles the industry must overcome for successful global market access: establishing clear clinical utility, navigating the complex reimbursement landscape with payers like CMS, addressing profound data privacy and security risks of neural data, and solving the ethical challenges of informed consent and long-term device support. - Is 2026 the year Brain-Computer Interfaces become a commercial reality? - What lessons can new neurotech companies learn from the commercial failure of the Argus II bionic eye? - How can developers prove value to payers like Medicare and private insurers to secure reimbursement? - What regulatory frameworks are needed to protect the privacy and security of sensitive neural data? - Who is responsible for a patient's BCI implant after a clinical trial ends or a company fails? - How does physician adoption impact the market access strategy for a novel medical device? - What are the key ethical considerations for informed consent in invasive BCI surgery? Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, streamlining global market access. We combine local expertise in over 30 markets with advanced AI and data tools to develop efficient regulatory strategies, compile technical dossiers, and manage submissions. From initial market research to post-market surveillance, our integrated approach ensures your innovative products, including advanced neurotechnology, reach patients faster. Let us help you navigate the complexities of international approvals and maintain compliance. Contact us at info@pureglobal.com, visit https://pureglobal.com, or explore our free AI tools and database at https://pureglobal.ai.
    Show More Show Less
    3 mins
  • AI Scribes & Ambient Documentation: A 2026 Clinical Infrastructure Forecast

    AI Scribes & Ambient Documentation: A 2026 Clinical Infrastructure Forecast
    Apr 8 2026
    This episode explores the future of AI in healthcare, focusing on whether ambient documentation and AI-powered charting will become standard clinical infrastructure by 2026. We weigh the technology's potential to reduce physician burnout and improve data quality against the significant barrier of provider trust, particularly concerning the accuracy of AI-generated notes in high-stakes medical environments. - Will ambient AI become a standard tool in most clinics by 2026? - How does AI-powered charting aim to solve the physician burnout crisis? - What are the primary accuracy concerns holding back provider adoption? - Can AI-generated clinical notes be trusted for critical medical decisions? - What regulatory hurdles must AI documentation software overcome to gain market access? - How will technology vendors prove the reliability and safety of their AI scribes? - What is the difference between ambient documentation and traditional dictation services? As pioneers in AI-powered medical devices and software seek to enter new territories, navigating the regulatory landscape is critical. Pure Global offers end-to-end consulting for MedTech and IVD companies, leveraging advanced AI tools to streamline global market access. We develop efficient regulatory strategies and manage technical dossier submissions to get your product approved faster. Whether you are a startup or a multinational enterprise, our global team provides the local expertise needed for success. Contact Pure Global at info@pureglobal.com, visit us at https://pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.
    Show More Show Less
    3 mins
No reviews yet